He was previously senior research fellow at the psychopharmacology unit, university of Bristol where he worked with Professor David Nutt for 16 years researching in the area of imidazoline receptor ligands, alpha2-adrenoceptor antagonists and their potential antidepressant activities. In Canada, Alan Hudson continues to explore the therapeutic potential of new imidazoline compounds using brain microdialysis in rodents to monitor monoamine turnover. He has also been investigating the neurochemistry of so called "legal highs" such as 1-benzylpiperazine which is also routinely found in ectstasy tablets in addition to methylenedioxymethamphetamine. Copyright 2011 Clinical Psychopharmacology. All Rights Reserved